新天地：公司抗流感病毒领域在研产品磷酸奥司他韦原料药、磷酸奥司他韦胶囊正按计划开展中

Group 1 - The company does not currently have any antiviral influenza pharmaceutical intermediates [2] - The company is developing two products in the antiviral influenza field: oseltamivir phosphate raw material and oseltamivir phosphate capsules, which are progressing as planned [2]